Investment
Features
FeesSafety
Academy
More
Pluang+

Copper and gold grades nearly double at Farellon mine as underground development reaches Level 9, boosting royalty revenue.

Market News
14 Oct 2026
Newsfile Corp
View Source
Bullish
Copper and gold grades nearly double at Farellon mine as underground development reaches Level 9, boosting royalty revenue.

Red Metal Resources reports that mining at the Farellon Project in Chile has advanced underground development from Level 7 to Level 9, with copper and gold grades nearly doubling in September compared to August. The lessee, Minera KMT, delivered 1,042 tonnes of ore to ENAMI's plant, generating approximately US$75,750 in settlement value and about US$6,440 in royalties for Red Metal. The company expects production to ramp up as mining progresses deeper, providing steady royalty income. Sampling and drilling efforts continue to support future development plans.

Red Metal's Farellon Mining update is provided here with Pluang's Basic Materials sector data for context. Of 83 priced US stocks in this sector, 44 rose and 33 fell today. Notable movers include TGB at USD 8.80 with a 1-day change of +2.80%, TECK at USD 65.50 down 2.49%, and ALB at USD 99.86 up 2.26%, as of Oct 14, 2026 16:01 WIB.

More News

CodeWall raises $4M to launch AI-driven autonomous attack agents for continuous enterprise security testing.

CodeWall raises $4M to launch AI-driven autonomous attack agents for continuous enterprise security testing.

CodeWall Ltd. has emerged from stealth with $4 million in pre-seed funding to develop AI-powered autonomous attack agents that simulate real-world cyberattacks on enterprises. These agents start from outside the network with no insider access, contin...

Others
Bullish
1 hour ago
Matchpoint Therapeutics names John O’Malley as Chief Medical Officer to advance autoimmune drug pipeline.

Matchpoint Therapeutics names John O’Malley as Chief Medical Officer to advance autoimmune drug pipeline.

Matchpoint Therapeutics has appointed John O’Malley, M.D., Ph.D., as its Chief Medical Officer. Dr. O’Malley brings extensive experience in immunology and clinical development from his previous roles at CRISPR Therapeutics and Sanofi. His leadership ...

Market News
Bullish
2 hours ago
FDA accepts Orvida Pharma's KM-023 into Rare Disease Evidence Principles process for Olmsted syndrome

FDA accepts Orvida Pharma's KM-023 into Rare Disease Evidence Principles process for Olmsted syndrome

Orvida Pharma announced that the FDA has accepted its lead drug candidate KM-023 (ontivatrep) into the Rare Disease Evidence Principles (RDEP) process for treating Olmsted syndrome, a rare genetic skin disorder. This acceptance allows Orvida to engag...

Market News
Bullish
2 hours ago
DMC Global to release Q3 2026 financial results on October 27 after market close

DMC Global to release Q3 2026 financial results on October 27 after market close

DMC Global Inc. will announce its financial results for the third quarter ending September 30, 2026, on October 27 after the stock market closes. The company will hold a conference call and webcast to discuss the results, providing investors with ins...

Company Fundamentals
Neutral
2 hours ago
Radware launches MCP Server Protection to secure AI integration layers from attacks and abuse.

Radware launches MCP Server Protection to secure AI integration layers from attacks and abuse.

Radware introduced its Model Context Protocol (MCP) Server Protection solution to help organizations secure the integration layer where AI agents connect to enterprise applications and workflows. This new security tool provides visibility into MCP in...

Market News
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App